Page last updated: 2024-08-23

du-21220 and Anemia, Hemolytic

du-21220 has been researched along with Anemia, Hemolytic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alcena, V	1

Other Studies

1 other study(ies) available for du-21220 and Anemia, Hemolytic

Article	Year
Severe hemolytic anemia, leukemoid reaction, acidosis, hypokalemia, and transient hepatitis associated with the administration of ritodrine hydrochloride (Yutopar). American journal of obstetrics and gynecology, 1982, Dec-01, Volume: 144, Issue:7 Topics: Acidosis; Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Female; Humans; Hypokalemia; Infant, Newborn; Leukemoid Reaction; Liver Function Tests; Male; Obstetric Labor, Premature; Pregnancy; Propanolamines; Ritodrine	1982

Article

Year

Severe hemolytic anemia, leukemoid reaction, acidosis, hypokalemia, and transient hepatitis associated with the administration of ritodrine hydrochloride (Yutopar).

American journal of obstetrics and gynecology, 1982, Dec-01, Volume: 144, Issue:7

Topics: Acidosis; Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Female; Humans; Hypokalemia; Infant, Newborn; Leukemoid Reaction; Liver Function Tests; Male; Obstetric Labor, Premature; Pregnancy; Propanolamines; Ritodrine

1982